SCHEMBL7534844

SCHEMBL7534844

CC(C)C(C(=O)NO)N(C)S(=O)(=O)c1ccc(Oc2ccc(Cl)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 14/20 0.62
MMP1 P03956 10/20 0.62
MMP13 P45452 10/20 0.62
ADAM17 P78536 6/20 0.62
MMP2 P08253 13/20 0.57
MMP8 P22894 6/20 0.57
MMP16 P51512 5/20 0.57
MMP3 P08254 4/20 0.57
MMP14 P50281 4/20 0.57
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA9 Q16790 2/20 0.49
PGR P06401 1/20 0.47
NPC1 O15118 1/20 0.46
MMP12 P39900 1/20 0.46
MTOR P42345 1/20 0.46
RAB9A P51151 1/20 0.46
MMP7 P09237 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7534841 1.00 MMP9 (0.62) MMP9MMP1MMP13ADAM17MMP2
SCHEMBL7537906 0.92 MMP9 (0.53) MMP9MMP1MMP13ADAM17MMP2
SCHEMBL7537902 0.92 MMP9 (0.53) MMP9MMP1MMP13ADAM17MMP2
SCHEMBL7533777 0.90 MMP9 (0.51) MMP9MMP1MMP13ADAM17MMP2
SCHEMBL7533782 0.90 MMP9 (0.51) MMP9MMP1MMP13ADAM17MMP2
SCHEMBL7533351 0.89 MMP9 (0.71) MMP9MMP1MMP13ADAM17MMP2
SCHEMBL7534926 0.89 MMP13 (0.64) MMP9MMP1MMP13ADAM17MMP2
SCHEMBL7532087 0.89 MMP9 (0.64) MMP9MMP1MMP13ADAM17MMP2
SCHEMBL7533354 0.89 MMP9 (0.71) MMP9MMP1MMP13ADAM17MMP2
SCHEMBL7532082 0.89 MMP9 (0.64) MMP9MMP1MMP13ADAM17MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US claimed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO claimed
US-H1992-H1 INHIBITION OF METALLOPROTEINASES AND TUMOR NECROSIS FACTOR CONVERTASE WHICH DEGRADE PROTEIN COMPONENTS OF EXTRACELLULAR MATRIX AGOURON PHARMACEUTICALS, INC. 2001-09-04 US disclosed
WO-1998050348-A1 METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AGOURON PHARMACEUTICALS, INC. (US) 1998-11-12 WO disclosed